| abstract |
The present invention provides methods for the design and synthesis of novel steroid compounds, both full length and splice variants, which cause down regulation of the androgen receptor (AR). The compounds are potential agents for treating all forms of prostate cancer and other diseases that are functional AR-dependent. |